Joseph S. Zakrzewski - 18 Jan 2024 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
Director
Signature
/s/ Lucy Day, Attorney-in-Fact for Joseph Zakrzewski
Issuer symbol
ANTX
Transactions as of
18 Jan 2024
Net transactions value
-$1,911,410
Form type
4
Filing time
19 Jan 2024, 19:32:12 UTC
Previous filing
09 Jun 2023
Next filing
08 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANTX Common Stock Sale $1,911,410 -100,000 -20% $19.11 405,880 18 Jan 2024 See footnote F1
holding ANTX Common Stock 98,199 18 Jan 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held by Z3 Trust, for which the Reporting Person is a trustee.

Remarks:

Exhibits: Power of Attorney